Table 1 Clinico-pathological variables for the patient cohort (n = 462)
From: The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer
Gender | Male | 266 (58%) |
|---|---|---|
| Â | Female | 196 (42%) |
Age (years) | Median | 72 |
|  | Range | 57–89 |
Status | Alive | 169 (37%) |
| Â | Dead (colorectal related) | 228 (49%) |
| Â | Dead (non-colorectal related) | 64 (14%) |
| Â | Unknown | 1 |
Tumour Grade | Well differentiated | 29 (6%) |
| Â | Moderately differentiated | 353 (77%) |
| Â | Poorly differentiated | 71 (15%) |
| Â | Unknown | 8 (2%) |
Tumour Site | Colon | 238 (52%) |
| Â | Rectum | 181 (39%) |
| Â | Unknown | 43 (9%) |
TNM Stage | 0 (Tis) | 3 (1%) |
| Â | 1 | 69 (15%) |
| Â | 2 | 174 (38%) |
| Â | 3 | 155 (33%) |
| Â | 4 | 54 (12%) |
| Â | Unknown | 7 (2%) |
Extramural Vascular Invasion | Negative | 224 (48%) |
| Â | Positive | 128 (28%) |
| Â | Unknown | 110 (24%) |
Histological type | Adenocarcinoma | 392 (85%) |
| Â | Mucinous carcinoma | 51 (11%) |
| Â | Columnar carcinoma | 4 (1%) |
| Â | Signet ring carcinoma | 7 (1%) |
| Â | Unknown | 8 (2%) |